Cystic Fibrosis drug recommended for PBS listing

By Sophie Elliott
Updated August 21 2018 - 5:10pm, first published August 17 2018 - 4:30pm

Orkambi, the revolutionary Cystic Fibrosis drug which treats the disease’s underlying cause, has been recommended by the Pharmaceutical Benefits Advisory Committee to be listed on the Pharmaceutical Benefits Scheme.

Get the latest Bunbury news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.